Cargando…
microRNA-128a dysregulation in transgenic Huntington’s disease monkeys
BACKGROUND: Huntington’s Disease (HD) is a progressive neurodegenerative disorder with a single causal mutation in the Huntingtin (HTT) gene. MicroRNAs (miRNAs) have recently been implicated as epigenetic regulators of neurological disorders, however, their role in HD pathogenesis is not well define...
Autores principales: | Kocerha, Jannet, Xu, Yan, Prucha, Melinda S, Zhao, Dongming, Chan, Anthony WS |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065582/ https://www.ncbi.nlm.nih.gov/pubmed/24929669 http://dx.doi.org/10.1186/1756-6606-7-46 |
Ejemplares similares
-
Longitudinal transcriptomic dysregulation in the peripheral blood of transgenic Huntington’s disease monkeys
por: Kocerha, Jannet, et al.
Publicado: (2013) -
A two years longitudinal study of a transgenic Huntington disease monkey
por: Chan, Anthony WS, et al.
Publicado: (2014) -
The Path to microRNA Therapeutics in Psychiatric and Neurodegenerative Disorders
por: Chan, Anthony W. S., et al.
Publicado: (2012) -
miR-196a Ameliorates Cytotoxicity and Cellular Phenotype in Transgenic Huntington’s Disease Monkey Neural Cells
por: Kunkanjanawan, Tanut, et al.
Publicado: (2016) -
MicroRNA Networks in Cognition and Dementia
por: Blount, Grace S., et al.
Publicado: (2022)